Estrogen receptor ligands.: Part 4:: The SAR of the syn-dihydrobenzoxathiin SERAMs

被引:34
作者
Kim, S
Wu, J
Chen, HY
Birzin, ET
Chan, WD
Yang, YT
Colwell, L
Li, S
Dahllund, J
DiNinno, F
Rohrer, SP
Schaeffer, JM
Hammond, ML
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Atherosclerosis & Endocrinol, Rahway, NJ 07065 USA
[3] Kar Biol AB, Novum, S-14157 Huddinge, Sweden
关键词
SERM; benzoxathiin; estrogen;
D O I
10.1016/j.bmcl.2004.03.074
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of estrogen receptor ligands based on a dihydrobenzoxathiin scaffold is described and evaluated for estrogen/anti-estrogen activity in both in vitro and in vivo models. The most active analogue, 22, was found to be 40-fold ERalpha selective in a competitive binding assay, and 22 demonstrated very potent in vivo antagonism of estradiol driven proliferation in an immature rat uterine weight gain assay. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2741 / 2745
页数:5
相关论文
共 11 条
[11]  
SHARMA AP, 1990, J MED CHEM, V33, P3229